138 related articles for article (PubMed ID: 36253573)
21. Water-soluble coenzyme Q10 provides better protection than lipid-soluble coenzyme Q10 in a rat model of chronic tacrolimus nephropathy.
Cui S; Luo K; Quan Y; Lim SW; Shin YJ; Lee KE; Kim HL; Ko EJ; Kim JH; Chung SJ; Bae SK; Chung BH; Yang CW
Korean J Intern Med; 2021 Jul; 36(4):949-961. PubMed ID: 33430574
[TBL] [Abstract][Full Text] [Related]
22. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152
[TBL] [Abstract][Full Text] [Related]
23. Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals.
Pravst I; Rodríguez Aguilera JC; Cortes Rodriguez AB; Jazbar J; Locatelli I; Hristov H; Žmitek K
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32188111
[TBL] [Abstract][Full Text] [Related]
24. Coenzyme Q10 stability in pediatric liquid oral dosage formulations.
Estévez PN; Tripodi V; Buontempo F; Lucangioli S
Farm Hosp; 2012; 36(6):492-7. PubMed ID: 23461442
[TBL] [Abstract][Full Text] [Related]
25. Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy.
Ding J; Zhao D; Hu Y; Liu M; Liao X; Zhao B; Liu X; Deng Y; Song Y
Int J Pharm; 2019 Nov; 571():118706. PubMed ID: 31593811
[TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
27. Systematically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation.
Yadav NK; Nanda S; Sharma G; Katare OP
J Drug Target; 2016; 24(3):257-71. PubMed ID: 26302815
[TBL] [Abstract][Full Text] [Related]
28. Coenzyme Q10 suppresses Th17 cells and osteoclast differentiation and ameliorates experimental autoimmune arthritis mice.
Jhun J; Lee SH; Byun JK; Jeong JH; Kim EK; Lee J; Jung YO; Shin D; Park SH; Cho ML
Immunol Lett; 2015 Aug; 166(2):92-102. PubMed ID: 26045320
[TBL] [Abstract][Full Text] [Related]
29. The Plasma Bioavailability of Coenzyme Q
Vitetta L; Leong A; Zhou J; Dal Forno S; Hall S; Rutolo D
J Funct Biomater; 2018 Dec; 9(4):. PubMed ID: 30558322
[TBL] [Abstract][Full Text] [Related]
30. The sialic acid residue of exogenous GM1 ganglioside is recycled for biosynthesis of sialoglycoconjugates in rat liver.
Ghidoni R; Trinchera M; Sonnino S; Chigorno V; Tettamanti G
Biochem J; 1987 Oct; 247(1):157-64. PubMed ID: 3689344
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis.
de Frutos F; Gea A; Hernandez-Estefania R; Rabago G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):254-9. PubMed ID: 25344142
[TBL] [Abstract][Full Text] [Related]
32. Self-Nanoemulsifying Drug Delivery System of Coenzyme (Q10) with Improved Dissolution, Bioavailability, and Protective Efficiency on Liver Fibrosis.
Khattab A; Hassanin L; Zaki N
AAPS PharmSciTech; 2017 Jul; 18(5):1657-1672. PubMed ID: 27677262
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.
Tang X; Sui D; Liu M; Zhang H; Liu M; Wang S; Zhao D; Sun W; Liu M; Luo X; Lai X; Liu X; Deng Y; Song Y
Int J Pharm; 2020 Nov; 590():119929. PubMed ID: 33010395
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10).
Schulz C; Obermüller-Jevic UC; Hasselwander O; Bernhardt J; Biesalski HK
Int J Food Sci Nutr; 2006; 57(7-8):546-55. PubMed ID: 17162333
[TBL] [Abstract][Full Text] [Related]
35. Investigation of ex vivo Skin Penetration of Coenzyme Q10 from Microemulsions and Hydrophilic Cream.
Tessema EN; Bosse K; Wohlrab J; Mrestani Y; Neubert RHH
Skin Pharmacol Physiol; 2020; 33(6):293-299. PubMed ID: 33212439
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.
Cleren C; Yang L; Lorenzo B; Calingasan NY; Schomer A; Sireci A; Wille EJ; Beal MF
J Neurochem; 2008 Mar; 104(6):1613-21. PubMed ID: 17973981
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors.
Hsu CH; Cui Z; Mumper RJ; Jay M
AAPS PharmSciTech; 2003; 4(3):E32. PubMed ID: 14621964
[TBL] [Abstract][Full Text] [Related]
38. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.
Crestanello JA; Doliba NM; Doliba NM; Babsky AM; Niborii K; Osbakken MD; Whitman GJ
J Surg Res; 2002 Feb; 102(2):221-8. PubMed ID: 11796022
[TBL] [Abstract][Full Text] [Related]
39. Pseudorotaxane-like supramolecular complex of coenzyme Q10 with gamma-cyclodextrin formed by solubility method.
Nishimura K; Higashi T; Yoshimatsu A; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2008 May; 56(5):701-6. PubMed ID: 18451562
[TBL] [Abstract][Full Text] [Related]
40. Acid and enzymatic hydrolysis of the internal sialic acid residue in native and chemically modified ganglioside GM1.
Rodriguez PE; Maggio B; Cumar FA
J Lipid Res; 1996 Feb; 37(2):382-90. PubMed ID: 9026535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
